Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/885074/000143774919020070/aghc20190630_10k.htm
SEC Filings
AGHC Annual Reports
AGHC Quarterly Reports
AGHC Corporate News
Other Events November 2019
Financial Exhibit
New Agreement
Unregistered Sales October 2019
Unregistered Sales March 2019
Interim Review January 2019
Vote of Security Holders January 2019
Other Events December 2018
Event for Officers
Vote of Security Holders December 2018
Event for Officers
Other Events October 2018
Event for Officers September 2018
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales July 2018
Other Events
November 2019
Financial Exhibit
New Agreement
Unregistered Sales
New Agreement
Unregistered Sales
October 2019
Unregistered Sales
March 2019
Interim Review
January 2019
Vote of Security Holders
January 2019
Other Events
December 2018
Event for Officers
Vote of Security Holders
Vote of Security Holders
December 2018
Event for Officers
Other Events
Other Events
October 2018
Event for Officers
September 2018
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales
New Agreement
New Financial Obligation
Unregistered Sales
July 2018
Last10K.com | 10-K Annual Report Tue Oct 15 2019
Document And Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2019 | Oct. 09, 2019 | Dec. 31, 2018 | |
| Document Information [Line Items] | |||
| Entity Registrant Name | Aeon Global Health Corp. | ||
| Entity Central Index Key | 0000885074 | ||
| Trading Symbol | aghc | ||
| Current Fiscal Year End Date | --06-30 | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Emerging Growth Company | false | ||
| Entity Small Business | true | ||
| Entity Common Stock, Shares Outstanding (in shares) | 9,915,064 | ||
| Entity Public Float | $ 7,383,706 | ||
| Entity Shell Company | false | ||
| Document Type | 10-K | ||
| Document Period End Date | Jun. 30, 2019 | ||
| Document Fiscal Year Focus | 2019 | ||
| Document Fiscal Period Focus | FY | ||
| Amendment Flag | false | ||
| Title of 12(g) Security | Common Stock |
View differences made from one year to another to evaluate Aeon Global Health Corp.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aeon Global Health Corp..
Assess how Aeon Global Health Corp.'s management team is paid from their Annual Proxy
Aeon Global Health Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Shareholders' Equity
Note 1 - Organization And Business
Note 10 - Earn-Out Merger Consideration
Note 10 - Earn-Out Merger Consideration (Details Textual)
Note 11 - Fair Value Measurement And Other Financial Instruments
Note 11 - Fair Value Measurement And Other Financial Instruments (Details Textual)
Note 11 - Fair Value Measurement And Other Financial Instruments (Tables)
Note 11 - Fair Value Measurement And Other Financial Instruments - Derivative Liabilities (Details)
Note 11 - Fair Value Measurement And Other Financial Instruments - Leases (Details)
Note 11 - Fair Value Measurement And Other Financial Instruments - Summary In Changes In Fair Value (Details)
Note 11 - Fair Value Measurement And Other Financial Instruments - Valuation Techniques (Details)
Note 12 - Commitments And Contingencies
Note 12 - Commitments And Contingencies (Details Textual)
Note 12 - Commitments And Contingencies (Tables)
Note 12 - Commitments And Contingencies - Leases And Debt Obligations (Details)
Note 13 - Related Party Transactions
Note 13 - Related Party Transactions (Details Textual)
Note 14 - Segment Information
Note 14 - Segment Information (Details Textual)
Note 14 - Segment Information (Tables)
Note 14 - Segment Information - Selected Financial Information (Details)
Note 15 - Subsequent Events
Note 15 - Subsequent Events (Details Textual)
Note 2 - Going Concern
Note 2 - Going Concern (Details Textual)
Note 3 - Summary Of Significant Accounting Policies
Note 3 - Summary Of Significant Accounting Policies (Details Textual)
Note 3 - Summary Of Significant Accounting Policies (Tables)
Note 3 - Summary Of Significant Accounting Policies - Revenues By Type Of Customers (Details)
Note 4 - Inventory
Note 5 - Property And Equipment
Note 5 - Property And Equipment (Details Textual)
Note 5 - Property And Equipment (Tables)
Note 5 - Property And Equipment - Property, Plant And Equipment Activity (Details)
Note 6 - Income Taxes
Note 6 - Income Taxes (Tables)
Note 6 - Income Taxes - Deferred Tax Assets And Liabilities (Details)
Note 6 - Income Taxes - Effective Income Tax Rate Reconciliation (Details)
Note 6 - Income Taxes - Schedule Of Income Tax Expense (Benefit) (Details)
Note 7 - Related Party Notes Payable
Note 7 - Related Party Notes Payable (Details Textual)
Note 7 - Related Party Notes Payable (Tables)
Note 7 - Related Party Notes Payable - Related Party Notes Payable (Details)
Note 8 - Shareholders' Equity
Note 8 - Shareholders' Equity (Details Textual)
Note 8 - Shareholders' Equity (Tables)
Note 8 - Shareholders' Equity - Earnings Per Share (Details)
Note 8 - Shareholders' Equity - Warrant Activity (Details)
Note 9 - Share-Based Compensation
Note 9 - Share-Based Compensation (Details Textual)
Note 9 - Share-Based Compensation (Tables)
Note 9 - Share-Based Compensation - Restricted Stock Unit Activity (Details)
Note 9 - Share-Based Compensation - Stock Option Activity (Details)
Significant Accounting Policies (Policies)
Material Contracts, Statements, Certifications & more
Aeon Global Health Corp. provided additional information to their SEC Filing as exhibits
Ticker: AGHC
CIK: 885074
Form Type: 10-K Annual Report
Accession Number: 0001437749-19-020070
Submitted to the SEC: Tue Oct 15 2019 4:35:28 PM EST
Accepted by the SEC: Tue Oct 15 2019
Period: Sunday, June 30, 2019
Industry: Medical Laboratories
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/aghc/0001437749-19-020070.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...